Global Point of Care Testing Market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024.
Infectious Diagnostics Rapid & Point of Care Tests Pipeline Review, 2015 provides an overview of Infectious Diagnostics Rapid & Point of Care Tests currently in pipeline stage. Enquiry about report: http://www.researchbeam.com/infectious-diagnostics-rapid-and-point-of-care-tests-pipeline-review-2015-market/enquire-about-report
Point-of-care Cholesterol Monitoring Device Market: Inclination Towards Portable Devices & Increasing Cholesterol Home Testing Trending the Global Market: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028
iGATE Research has released a research report on “Global Point of Care Testing Market (By Diagnostics Segment, Mode, End Users, Regions), 100 Company Profiles - Forecast to 2025” Click here to view the complete report: www.igateresearch.com Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com
The Business Research Company’s Diabetes Care Devices Market By Segments (Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors), By Applications, By Trends And By Regions – Global Forecast To 2022 covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. http://bit.ly/33uCTn0
This TriMark Publications report “Point of Care Diagnostic Testing World Markets” describes latest developments in the point of care testing market segment. For more details : http://goo.gl/6pZ2p8
Point-of-care coagulation testing devices market is projected to expand at a CAGR of ~6% during the forecast period, leading players in the market focus on new products with multiple modes and features, which will be more efficient and deliver a new level.
Global Ultrasound Devices Market accounted to USD 7 billion in 2018 to an estimated value of USD 9.3 billion by 2026 growing at a CAGR of 4.5% during the forecast period of 2019 to 2026. The upcoming market report contains data for historic years 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.
The Report on “Point of Care POC Testing Market Size, Share, Growth, Profit, Analysis, Trends and Strategy 2015" added by Research Beam Enquiry about report: http://www.researchbeam.com/2015-emerging-point-of-care-poc-testing-cancer-clinics-ambulatory-centers-surgery-centers-nursing-homes-birth-centers-supplier-shares-volume-and-sales-forecasts-for-300-tests-market/enquire-about-report
Global Point of Care Testing Market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024.
Avail more information from Sample Brochure of report @ http://tinyurl.com/gre5az9 This new 1,230-page report contains 343 tables, and provides a comprehensive analysis of the 10 major POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies. Read analysis @ http://tinyurl.com/jklw5v3
The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry. Technical advancements over recent years have helped point of care testing (POCT) to grow with double digit CAGR from 2009 to 2011 and evolve into a vital diagnostic tool. It is predicted that point of care testing market will be approximately US$ 25 Billion by 2016.
The report on In-vitro Diagnostics Instruments Market by product (immunochemistry, clinical microbiology, POCT, tissue diagnostics, molecular diagnostics, hematology, hemostasis, SMBG), end user(hospitals and diagnostic laboratories, research institutes) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global In-vitro Diagnostics Instruments Market is projected to grow at a CAGR of 9.3% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
Global Point of Care Technology Market Information by Product Type (Glucose Testing, Cardiac Markers, Hb1Ac Testing, Coagulation), by Instrument (Blood Glucose Meter), by End User (Clinics, Hospital, Home Care, Ambulatory Care) - Forecast to 2027
This 340-page report contains 36 tables, and provides a comprehensive analysis of the POC lipid testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC lipid testing market. Read more: http://www.researchbeam.com/2015-2019-future-horizons-and-growth-strategies-in-the-point-of-care-poc-lipid-testing-supplier-shares-and-country-forecasts-market
Access full Research: https://www.renub.com/point-of-care-testing-market-and-forecast-to-2016-global-analysis-158-p.php Point of Care Testing Market is anticipated to be US$ 36 Billion, by 2024 experiencing a significant growth over the forecast period. The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry.
As per FMI’s analysis, the following players operate within the global zika virus testing market: EUROIMMUN US Inc. Creative Diagnostics Quest Diagnostics Artron Laboratories Inc. RapiGEN Inc.
Blood coagulation or coagulation is the method through which blood shifts from liquid to gel, creating clots. These clots lead to bleeding cessation. However, in individuals with liver disease, thrombophilia, and hemophilia, the coagulation process is hindered. Different testing processes for blood coagulation are used to diagnose these illnesses, which provide the hemostatic functioning status of the patients
Cardiac biomarkers market is expected to accrue strong growth in forecast period 2019 to 2025. The global market provides in-depth industry analysis with free additional customization, including the impact of the COVID-19 pandemic, published by MRFR.
According to MRFR Analysis – blood testing market research is expected to accrue strong growth in forecast period 2017 to 2023. The global market research report provides in-depth industry analysis with free additional customization, including the impact of the COVID-19 pandemic.
STD testing market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 154347.8 million by 2027 growing at a CAGR of 7.35% in the above-mentioned forecast period. Increasing cases of gonorrhoea & chlamydia and rising public awareness about STD are the factors which will create new opportunities for the STD testing market in the forecast period of 2020 to 2027.
Global Ultrasound Devices Market accounted to USD 7 billion in 2018 to an estimated value of USD 9.3 billion by 2026 growing at a CAGR of 4.5% during the forecast period of 2019 to 2026. The upcoming market report contains data for historic years 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.
Global Point of Care Diagnostics (POC) Market Analysis By Product, By Application, And Segment Forecasts To 2020 is a latest Medical Devices Industry report.
A latest research report “Home Health Care And Residential Nursing Care Services Global Market Report” proposed by The Business Research Company provides a market summary on Market Analysis, Size, Trends and Growth. Read Full Report @ http://bit.ly/2XMvmfM Get Free Sample Copy @ http://bit.ly/2PzMtyA
A new market study based on the Point Of Care Diagnostics Market designed from various sources which also include porter's five forces analysis research techniques to explore the new opening of the market for the period of 2019-2025. The study also interrogates and examines the information based on share, market size, growth path, and the latest trends to recognize the potential value of the market. And most importantly, the data on the current business scenario will also help players to understand the stakeholder strategies and discover the new opportunities which will help them to succeed in their way.
The Global Point Of Care Diagnostics Market size was valued for $22,975 million in 2015 and is expected to reach $43,336 million by 2022, growing at a CAGR of 9.4% from 2016 to 2022. The point of care (POC) diagnostics defined in this report are the medical devices used to get an immediate result in the investigation (diagnosis & monitoring) of various diseases such as cancer, diabetes, cardiac diseases, and others. Request sample copy of this report at: https://www.alliedmarketresearch.com/request-sample/161
Big Market Research has announced a new Report Package "World Factor Assays Testing Market- Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential 2019" Get Complete Report at: http://www.bigmarketresearch.com/2015-world-factor-assays-testing-ambulatory-centers-commercial-labs-hospitals-physician-offices-poc-point-of-care-locations-competitive-landscape-country-segment-forecasts-innovative-technologies-inst-market The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and Factor Assays testing specifically, will become more standardized, offering opportunities for quality control products and services. Enquire about this report at: http://www.bigmarketresearch.com/report-enquiry/330942
Point-of-care (POC) tests are diagnostic tests that are performed at or near the site where the patient is located. They are performed in decentralized settings, outside of central hospital laboratories or centralized reference laboratories.
Allied Market Research has recently published a report on the point of care diagnostics market, which is a comprehensive study of the entire industry for the period of 2014–2022.
The acute coronary syndrome sub-segment under application segment is projected to dominate the global “cardiac biomarkers market during the forecast period.
Research Beam added report on “Global Medical Automation Technologies Market 2015 - 2022”. The Global Medical Automation Technologies Market is estimated to be $48.4 billion in 2014 and is expected to reach $95.2 billion growing at a CAGR of 8.82% from 2014 to 2022. The factors that are influencing the market growth include rising healthcare costs, investment by venture capitalists and the increase in use of point of care testing devices (glucose meters, digital blood pressure monitors, pregnancy test kits and HIV test kits). However the tax imposed by the U.S government on medical devices manufacturers and rigorous approval procedures to launch a product or services by companies is likely to hinder the market growth. The rising need of automation in various other medical fields represents the growth opportunities for this market. Enquiry @ http://www.researchbeam.com/global-medical-automation-technologies-outlook-2014-2022-market/enquire-about-report
The molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease. The United States is the key market for molecular diagnostics due to the availability of government funds, rising incidence of chronic diseases, the availability of different types of tests, and high awareness of pharmacogenomics/personalized medicine. Moreover, major companies have easy access to United States which makes the United States the largest and most significant market for suppliers. Click here to view the complete report: http://www.igateresearch.com/ProductDetail.php?pd_name=United%20States%20-%20Molecular%20Diagnostics%20Market,%20Test%20Volume%20and%20Company%20Analysis%20to%202020
Big Market Research “Global Medical Automation Technologies Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/global-medical-automation-technologies-outlook-2014-2022-market The report “Global Medical Automation Technologies Market” is the result of an in-depth analysis by market professionals with valuable inputs from industry experts. The report offers a comprehensive insight into the recent business overview, current and future market trends, key drivers and restraints along with detailed segmentation and forecast. The global medical automation technologies market was evaluated at $48.4 billion in 2014 and would reach $95.2 billion registering 8.82% CAGR during 2014-2022.
The factors such as new regulations and standards, outsourcing of the testing, inspection, and certification services, concern about product quality and safety, and globalization of the trade are driving the testing, inspection, and certification market.
The report on In Vitro Diagnostics Market by test location (Central lab, Point of Care and Self-test/OTC), by region (North America, Europe, Asia Pacific and rest of the world) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global In Vitro Diagnostics Market is projected to grow at a CAGR of 6.0% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
The report on Infectious Disease Testing Market by Infinium Global Research analyzes the Infectious Disease Testing Market over the period of 2017 to 2023. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in Global Infectious Disease Testing Market. It will help a lot of decision makers to develop strategies and find new opportunities in the Global Infectious Disease Testing Market.
To Get More Details @ http://www.bigmarketresearch.com/in-vitro-diagnostic-ivd-market “Big Market Research : In Vitro Diagnostics (IVD) Market - Global Industry Analysis, Growth, Trends, Opportunities, Size, Share and Forecast, 2012 – 2020 In vitro diagnostics (IVD) is the technique of diagnostic test outside the human body in an artificial environment. The IVD market revenue is expected to reach $74.65 billion by 2020, from the market value of $53.32 billion in 2013, at a CAGR of 5.34% during 2014-2020. The global IVD market is segmented based on techniques, product type, usability, application, end user and geography (North America, Europe, Asia Pacific and Rest of World). Geographically, Asia Pacific is the fastest growing region and very opportune market that would generate highest revenue by 2020
The rising incidence of infectious diseases and shift in focus from centralized laboratories to decentralized (POC) point-of-care testing is driving the market demand.
Microfluidics Market: Point of Care Testing Segment Anticipated to Register High Revenue Growth over the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016–2026
Point-of-care (POC) diagnostics or near-patient testing is a medical diagnostic test that allows physicians and medical staff to correctly attain real-time, lab-quality diagnostic results within minutes rather than hours.
Major Players in the Blood Glucose Test Strips Market are F. Hoffmann-La Roche AG, LifeScan, Inc., Abbott Laboratories, Ascensia Diabetes Care Holdings AG, Terumo Corporation Read more @ https://bit.ly/2RJEiW7